FDA.reportPublic FDA data

etripamil 35 MG/ACTUAT Nasal Spray

RxCUI
2730307
RxNorm name
etripamil 35 MG/ACTUAT Nasal Spray
Display name
etripamil 35 MG/ACTUAT Nasal Spray
Full name
etripamil 35 MG/ACTUAT Nasal Spray
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CardamystETRIPAMILMilestone Pharmaceuticals USA, Inc.a92170b9-4f93-4b83-b2cd-cb85c52821cd2025-12-08Warnings, Adverse reactionsExact identifier
rxcui: 2730307

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a92170b9-4f93-4b83-b2cd-cb85c52821cdetripamil 35 MG/ACTUAT Nasal SprayPSN1These highlights do not include all the information needed to use CARDAMYST TM safely and effectively. See full prescribing information for CARDAMYST TM . CARDAMYST TM (etripamil) nasal spray Initial U.S. Approval: 202520251208
a92170b9-4f93-4b83-b2cd-cb85c52821cdetripamil 35 MG/ACTUAT Nasal SpraySCD1These highlights do not include all the information needed to use CARDAMYST TM safely and effectively. See full prescribing information for CARDAMYST TM . CARDAMYST TM (etripamil) nasal spray Initial U.S. Approval: 202520251208